Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Will Revenue Growth Aid Marsh & McLennan (MMC) Q3 Earnings?

Published 10/23/2017, 11:47 PM
Updated 07/09/2023, 06:31 AM

Marsh & McLennan Companies, Inc. (NYSE:MMC) third-quarter results, scheduled for Oct 26, are expected to benefit from increased revenues at both its operating segments, namely Risk and Insurance Services and Consulting.

Revenues in the company’s Risk and Insurance Services segment, which contributes nearly 55% to total revenues, have been growing for the past several quarters and we expect the trend to continue in the quarter. Top-line growth will be aided by an increase in underlying revenues along with accretion from numerous acquisitions made during the course of the past many years. The Zacks Consensus Estimate for revenues for the segment is $1.7 billion, up 6.3% year over year.

Also, higher contribution is expected from Consulting. A combination of organic and inorganic growth measures are likely to drive revenues in this segment. The Zacks Consensus Estimate for revenues for the segment is $1.6 billion, up 5.8% year over year.

The company is expanding in underpenetrated regions such as Latin America, Asia, the Middle East and South Africa, which are perceived as high growth areas. Performance from these regions is likely to aid overall results.

Along with pushing into attractive geographical regions, the company is expanding in new businesses which should drive revenues. These include Marsh’s build out of MMA and its UK SME strategy, the emergence of cyber, flood and mortgage practices at Marsh and Guy Carpenter, investments at Mercer in Workday implementation capabilities, global health and benefits technology and the Mercer Marketplace Health Exchange, investments in Oliver Wyman and their digital technology and analytics platform, and continued pursuit of high-growth areas, including healthcare and the public sector.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Here is what our quantitative model predicts:

Our proven model shows that Marsh & McLennan does not have the right combination of the two key ingredients, of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better, to beat earnings estimates.

Zacks ESP: Earnings ESP, which represents the difference between the Most Accurate estimate and the Zacks Consensus Estimate, is -0.53%. This is because the Most Accurate estimate of 77 cents per share is a penny below the Zacks Consensus Estimate. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Zacks Rank: Though Marsh & McLennan carries a Zacks Rank #2 (Buy), which increases the predictive power of ESP, its negative ESP makes surprise prediction difficult.

We caution against Sell-rated stocks (#4 or 5) going into an earnings announcement, especially when the company is seeing negative estimate revisions.

Marsh & McLennan Companies, Inc. Price and EPS Surprise

Other Stocks

Here are some companies worth considering as our model shows that these possess the right combination of elements to beat estimates this quarter:

Amerisafe Inc. (NASDAQ:AMSF) will report third-quarter 2017 earnings results on Oct 25. The company has an Earnings ESP of +3.04% and carries a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.

Anthem Inc. (NYSE:ANTM) has an Earnings ESP of +1.55% and a Zacks Rank of 3. The company is scheduled to report third-quarter earnings results on Oct 25.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Aflac Inc. (NYSE:AFL) has an Earnings ESP of +1.31%. This Zacks #3 Ranked company is scheduled to report third-quarter earnings results on Oct 25.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>



Aflac Incorporated (AFL): Free Stock Analysis Report

AMERISAFE, Inc. (AMSF): Free Stock Analysis Report

Marsh & McLennan Companies, Inc. (MMC): Free Stock Analysis Report

Anthem, Inc. (ANTM): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.